KRAS G12C inhibitor 39
Modify Date: 2025-08-22 18:31:18
KRAS G12C inhibitor 39 structure
|
Common Name | KRAS G12C inhibitor 39 | ||
|---|---|---|---|---|
| CAS Number | 2326522-16-9 | Molecular Weight | 645.80 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C37H43N9O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of KRAS G12C inhibitor 39KRAS G12C inhibitor 39 is a potent inhibitor of KRAS G12C. KRas is a highly attractable target of the pharmaceutical industry for cancer research. KRAS G12C inhibitor 39 has the potential for the research of KRAS G12C-mediated cancer (extracted from patent WO2019099524A1, compound 494)[1]. |
| Name | KRAS G12C inhibitor 39 |
|---|
| Description | KRAS G12C inhibitor 39 is a potent inhibitor of KRAS G12C. KRas is a highly attractable target of the pharmaceutical industry for cancer research. KRAS G12C inhibitor 39 has the potential for the research of KRAS G12C-mediated cancer (extracted from patent WO2019099524A1, compound 494)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. James F. Blake, et al. Kras g12c inhibitors. Patent WO2019099524A1. |
| Molecular Formula | C37H43N9O2 |
|---|---|
| Molecular Weight | 645.80 |
| InChIKey | XLWQRAXKTKNFIV-QFFHNCJUSA-N |
| SMILES | Cc1cccc2cccc(N3CCc4c(nc(OCC5CCCN5C)nc4N4CCN(C(=O)C=Cc5cnn(C)c5)C(CC#N)C4)C3)c12 |